Global Digital Sphygmomanometer Market By Product Type (Arm Type and Wrist Type), By End-user (Hospitals, Ambulatory Surgical Centers & Clinics, Homecare Settings, and Others), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033

Report Overview

Global Digital Sphygmomanometer Market size is expected to be worth around US$ 7.8 billion by 2033 from US$ 3.5 billion in 2023, growing at a CAGR of 8.4% during the forecast period 2024 to 2033.

Increasing prevalence of hypertension drives significant growth in the digital sphygmomanometer market, as more individuals require accurate blood pressure monitoring for effective health management. According to a World Health Organization (WHO) press release from August 2021, the number of people aged 30 to 79 years living with hypertension surged from 650 million to 1.28 billion over the past three decades.

This sharp increase highlights the urgent need for reliable and user-friendly blood pressure monitoring devices. Digital sphygmomanometers provide convenience and precision, facilitating both home and clinical use, which aligns with the rising trend toward telehealth and remote patient monitoring.

Recent technological advancements have enhanced the accuracy and functionality of these devices, incorporating features such as Bluetooth connectivity for seamless data transfer to smartphones and healthcare systems. The growing demand for preventive healthcare solutions further supports market expansion, as healthcare providers and patients increasingly focus on early detection and management of cardiovascular conditions.

Opportunities arise in the geriatric population, where accessibility and ease of use become crucial for regular monitoring. As health awareness increases globally, the digital sphygmomanometer market is poised for sustained growth, driven by innovations that enhance user experience and healthcare outcomes. The emphasis on smart health technologies will likely shape future developments, making blood pressure monitoring more efficient and integrated into daily health routines.

Key Takeaways

• In 2023, the market for digital Sphygmomanometer Market generated a revenue of US$ 3.5 billion, with a CAGR of 8.4%, and is expected to reach US$ 7.8 billion by the year 2033.
• The product type segment is divided into arm type and wrist type, with arm type taking the lead in 2023 with a market share of 68.5%.
• Considering end-user, the market is divided into hospitals, ambulatory surgical centers & clinics, homecare settings, and others. Among these, homecare settings held a significant share of 45.2%.
• North America led the market by securing a market share of 39.7% in 2023.

By Product Type Analysis

The arm type segment led in 2023, claiming a market share of 68.5% owing to its accuracy and reliability in measuring blood pressure. Arm-type devices offer a more consistent and precise measurement compared to wrist-type models, making them the preferred choice for both healthcare professionals and consumers. The rising awareness of hypertension and cardiovascular diseases drives demand for effective blood pressure monitoring tools, further bolstering the arm type segment.

Additionally, advancements in technology have led to the development of more user-friendly and sophisticated arm-type devices, which incorporate features like Bluetooth connectivity and automatic readings. Increased emphasis on preventive healthcare encourages individuals to monitor their blood pressure regularly, contributing to the segment’s growth.

Furthermore, the aging population, who often require regular health monitoring, favors arm-type sphygmomanometers due to their accuracy. These combined factors are likely to enhance the market position of the arm type segment in the coming years.

By End-user Analysis

The homecare settings held a significant share of 45.2% as more individuals prefer to manage their health from the comfort of their homes. The rising prevalence of chronic diseases, such as hypertension and diabetes, drives demand for convenient home monitoring solutions, which makes digital sphygmomanometers increasingly popular among patients.

As healthcare systems shift towards patient-centered care and emphasize preventive health measures, home monitoring becomes essential for managing conditions effectively. Technological advancements have resulted in devices that are easy to use, portable, and capable of providing accurate readings, making them appealing to a broad audience.

Additionally, the COVID-19 pandemic has accelerated the adoption of home health solutions, as patients seek to minimize hospital visits. Insurance coverage for home monitoring devices also enhances accessibility, encouraging patients to invest in their health management. Consequently, these factors position homecare settings as a crucial growth segment within the digital sphygmomanometer market.

Key Market Segments

By Product Type

• Arm Type
• Wrist Type

By End-user

• Hospitals
• Ambulatory Surgical Centers & Clinics
• Homecare Settings
• Others

Drivers

Rise in Innovation Drives the Market

Rising innovation significantly drives the digital sphygmomanometer market. In January 2023, iProven, a prominent manufacturer of healthcare devices, launched the BPM-417 Blood Pressure Monitor, which incorporates a range of innovative features designed to enhance user experience.

This device includes a unique wrist guide position that helps users correctly position their wrist for accurate blood pressure readings. Such advancements reflect the industry’s focus on improving ease of use, accuracy, and functionality in home monitoring devices. The development of smart features, such as Bluetooth connectivity and app integration, further enhances user engagement and data tracking.

As manufacturers continue to innovate, they are expected to meet the increasing consumer demand for reliable and user-friendly blood pressure monitoring solutions. This trend towards innovation supports market expansion by attracting health-conscious consumers who seek efficient ways to manage their cardiovascular health.

Restraints

High Instance of Inaccurate Readings Restrains the Market

High instances of inaccurate readings restrain the growth of the digital sphygmomanometer market. Variability in blood pressure readings can stem from improper device usage, incorrect cuff sizes, or external factors such as user stress and body position. These inaccuracies may lead to misdiagnosis or inappropriate treatment decisions, causing healthcare professionals and patients to lose confidence in these devices.

The prevalence of false readings likely impedes the widespread adoption of digital sphygmomanometers, as consumers may prefer traditional methods perceived to be more reliable. Additionally, concerns regarding device calibration and maintenance can further hamper market growth.

Manufacturers face pressure to enhance accuracy and reduce errors, which necessitates investment in quality control and technology improvement. Therefore, addressing these accuracy concerns is crucial for fostering trust and ensuring sustained market development.

Opportunities

Growing Popularity of Remote Patient Monitoring Services

Growing popularity of remote patient monitoring services presents significant opportunities for the digital sphygmomanometer market. In January 2022, OMRON Healthcare, Inc. launched remote patient monitoring services aimed at broadening digital health initiatives to support individuals throughout their heart health journey.

This service enhances patient-physician connections and encourages behavior change while minimizing health risks. The integration of digital sphygmomanometers into remote monitoring systems allows patients to track their blood pressure conveniently at home, providing healthcare professionals with real-time data for better decision-making.

As healthcare systems increasingly embrace telehealth and remote monitoring solutions, the demand for accurate and reliable home blood pressure monitors is expected to surge. This trend not only enhances patient engagement but also aligns with the industry’s shift towards preventive care and chronic disease management, positioning the digital sphygmomanometer market for substantial growth.

Impact of Macroeconomic / Geopolitical Factors

Macroeconomic and geopolitical factors significantly shape the digital sphygmomanometer market, influencing production, demand, and pricing dynamics. Economic growth boosts healthcare spending, leading to increased investments in medical devices, including blood pressure monitors.

Conversely, economic downturns can constrain budgets for healthcare facilities, limiting their ability to upgrade equipment. Geopolitical tensions and trade policies can disrupt supply chains, affecting the availability of key components necessary for manufacturing these devices. Moreover, fluctuating raw material costs can impact the pricing of digital monitors, making them less accessible for some healthcare providers.

However, the rising prevalence of hypertension globally drives demand for effective monitoring solutions, creating opportunities for market expansion. Furthermore, supportive government initiatives to enhance healthcare access and quality ensure a positive outlook for the market. As healthcare providers increasingly prioritize patient management, the digital sphygmomanometer market is well-positioned for growth.

Latest Trends

Rising Integration of AI and Machine Learning Driving Growth in the Digital Sphygmomanometer Market

Rising integration of artificial intelligence (AI) and machine learning significantly drives growth in the digital sphygmomanometer market. Companies increasingly embed advanced algorithms into their devices to enhance accuracy, reliability, and user experience. This trend is expected to revolutionize hypertension management by providing real-time data analysis and personalized health insights.

For instance, on January 4, 2024, Nanowear announced that its SimpleSense platform received U.S. FDA 510(k) approval for an innovative AI-enabled Software-as-a-Medical Device (SaMD), marking a milestone in remote diagnostics. SimpleSense-BP, the first non-invasive, cuffless, continuous blood pressure monitor, transforms clinical diagnostic management of hypertension.

The integration of AI facilitates better patient monitoring and timely interventions, leading to improved health outcomes. As healthcare systems increasingly adopt smart technologies, the demand for intelligent monitoring solutions is likely to surge, positioning the market for sustained growth.

Regional Analysis

North America is leading the Digital Sphygmomanometer Market

North America dominated the market with the highest revenue share of 39.7% owing to an increasing awareness of hypertension and the importance of regular blood pressure monitoring. The rise in lifestyle-related health issues, such as obesity and sedentary behavior, has led to a growing prevalence of hypertension, necessitating reliable and accurate monitoring devices for both patients and healthcare providers.

The completion of Baxter’s acquisition of Hillrom in December 2021 further enhanced market dynamics by expanding Baxter’s ability to serve clinicians and patients through advanced medical supplies and hospital equipment. This strategic move opened new growth opportunities for Baxter, enabling the integration of innovative sphygmomanometers into healthcare settings.

Additionally, the shift toward telehealth solutions and home monitoring has accelerated the adoption of digital sphygmomanometers, as these devices offer convenience and ease of use. The combination of technological advancements and a focus on preventive healthcare is propelling the market forward, positioning digital sphygmomanometers as essential tools in managing cardiovascular health in North America.

The Asia Pacific region is expected to experience the highest CAGR during the forecast period

Asia Pacific is expected to grow with the fastest CAGR owing to increasing healthcare awareness and advancements in telehealth technologies. Rapid urbanization and lifestyle changes have contributed to a surge in hypertension cases, prompting the need for efficient monitoring solutions.

In December 2021, OMRON Healthcare, a subsidiary of Omron Corporation, collaborated with Doctor Anywhere, a regional omnichannel healthcare platform. This partnership allows for the integration of OMRON’s smart health monitoring devices with Doctor Anywhere’s telehealth platform, enhancing digital health management and facilitating remote hypertension programs. Such initiatives highlight the growing emphasis on digital health solutions across the region, making blood pressure monitoring more accessible.

Furthermore, government initiatives aimed at improving healthcare infrastructure and promoting preventive care are likely to support market growth. With these factors, the Asia Pacific digital sphygmomanometer market is anticipated to expand as healthcare systems evolve to meet the increasing demand for effective hypertension management solutions.

Key Regions and Countries

North America

• US
• Canada

Europe

• Germany
• France
• The UK
• Spain
• Italy
• Russia
• Netherland
• Rest of Europe

Asia Pacific

• China
• Japan
• South Korea
• India
• Australia
• New Zealand
• Singapore
• Thailand
• Vietnam
• Rest of APAC

Latin America

• Brazil
• Mexico
• Rest of Latin America

Middle East & Africa

• South Africa
• Saudi Arabia
• UAE
• Rest of MEA

Key Players Analysis

The major players in the digital sphygmomanometer market are actively engaged in the development and introduction of innovative products, as well as implementing strategic initiatives aimed at enhancing their competitive positioning. Key players in the digital sphygmomanometer market employ several strategies to enhance growth and capture market share.

They focus on innovation by developing advanced devices that integrate smart technology, such as Bluetooth connectivity and mobile app compatibility, improving user experience and data management. Collaborations with healthcare professionals and organizations facilitate clinical validation and increase trust in their products. Companies also expand their distribution channels, targeting both online and retail environments to reach a broader audience.

Additionally, they emphasize marketing campaigns that educate consumers about the importance of monitoring blood pressure, thereby driving demand for their advanced monitoring solutions.

Top Key Players

• Withings
• SunTech Medical, Inc.
• Omron Healthcare
• GE Healthcare
• Contec
• Briggs Healthcare
• Braun Healthcare
• Biobeat
• American Diagnostics Corp.
• Aktiia

Recent Developments

• On February 27, 2024, Aktiia, a Switzerland-based health tech innovator, announced the completion of a USD 30 million (CHF 27 million) investment round led by Redalpine. This strategic capital infusion will enable Aktiia to enhance its efforts in reducing the global burden of hypertension through AI-driven technology for blood pressure management, which is already utilized by over 60,000 customers and numerous healthcare organizations. This development is relevant to the digital sphygmomanometer market as it signifies a growing investment in innovative technologies aimed at improving hypertension management, which can drive demand for digital monitoring devices.
• In November 2022, OMRON Healthcare partnered with CardioSignal, a certified mobile application for early cardiovascular disease detection. This collaboration aims to advance the early detection of cardiovascular conditions, assisting clinicians in population health management. The partnership focuses on creating digital health solutions that streamline workflows for managing lifestyle chronic diseases, particularly cardiovascular issues, using OMRON’s ECG and motion sensor technologies. This initiative supports the growth of the digital sphygmomanometer market by integrating advanced technology into routine monitoring and enhancing the overall efficacy of blood pressure management solutions.
• In May 2021, Biobeat, a leader in wearable remote patient monitoring solutions, launched its continuous ambulatory blood pressure monitoring (ABPM) chest monitor. This disposable wearable monitor allows for easy and intuitive self-setup by patients, requiring no clinician assistance. The introduction of such user-friendly devices is significant for the digital sphygmomanometer market, as it addresses the need for accessible, continuous monitoring solutions that empower patients to manage their blood pressure effectively.

Report Scope